180 related articles for article (PubMed ID: 28540896)
21. Skin cancer after renal transplantation: Results of a multicenter study in Iran.
Einollahi B; Nemati E; Lessan-Pezeshki M; Simforoosh N; Nourbala MH; Rostami Z; Nafar M; Pourfarziani V; Beiraghdar F; Mahdavi-Mazdeh M; Ahmadpour P; Makhdoomi K; Ghafari A; Ardalan MR; Taebi Khosroshahi H; Oliaei F; Shahidi S; Makhlogh A; Azmandian J; Samimagham HR; Shabazian H
Ann Transplant; 2010; 15(3):44-50. PubMed ID: 20877266
[TBL] [Abstract][Full Text] [Related]
22. Posttransplant lymphoproliferative disorders in kidney transplant recipients: an Iranian multicenter experience.
Einollahi B; Lessan-Pezeshki M; Nourbala MH; Simforoosh N; Pourfarziani V; Nemati E; Nafar M; Basiri A; Pour-Reza-Gholi F; Firoozan A; Ghadiani MH; Makhdoomi K; Ghafari A; Ahmadpour P; Oliaei F; Ardalan MR; Makhlough A; Samimagham HR; Azmandian J; Razeghi E; Shahbazian H
Iran J Kidney Dis; 2008 Oct; 2(4):227-33. PubMed ID: 19377242
[TBL] [Abstract][Full Text] [Related]
23. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
Wasson S; Zafar MN; Best J; Reddy HK
J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
[TBL] [Abstract][Full Text] [Related]
24. Malignancy in Kidney Transplantation: A 25-Year Single-center Experience in Portugal.
Aguiar B; Santos Amorim T; Romãozinho C; Santos L; Macário F; Alves R; Campos M; Mota A
Transplant Proc; 2015 May; 47(4):976-80. PubMed ID: 26036498
[TBL] [Abstract][Full Text] [Related]
25. Malignancy after renal transplantation in the new era of immunosuppression.
Watorek E; Boratynska M; Smolska D; Patrzalek D; Klinger M
Ann Transplant; 2011; 16(2):14-8. PubMed ID: 21716180
[TBL] [Abstract][Full Text] [Related]
26. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
Jain M; Badwal S; Pandey R; Srivastava A; Sharma RK; Gupta RK
Clin Transplant; 2005 Oct; 19(5):668-73. PubMed ID: 16146560
[TBL] [Abstract][Full Text] [Related]
27. Effect of pretransplant hepatitis C virus on the development of new-onset diabetes mellitus after transplant in Egyptian living-donor renal allotransplant recipients at Mansoura Urology and Nephrology Center.
Abbas MH; Ismail MI; El Deeb SA; Nagib AM; Hassan NM; Refaie AF; El Maghrabi HM; Denewar AA; Bakr MA
Exp Clin Transplant; 2015 Feb; 13(1):26-34. PubMed ID: 25654411
[TBL] [Abstract][Full Text] [Related]
28. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
[TBL] [Abstract][Full Text] [Related]
29. Outcome of Kaposi's sarcoma and graft following discontinuation of immunosuppressive drugs in renal transplant recipients.
Firoozan A; Hosseini Moghaddam SM; Einollahi B; Pour-Reza-Gholi F; Nafar M; Basiri A; Ebrahimi-Rad R
Transplant Proc; 2005 Sep; 37(7):3061-4. PubMed ID: 16213305
[TBL] [Abstract][Full Text] [Related]
30. Kaposi's sarcoma following living donor kidney transplantation: review of 7,939 recipients.
Einollahi B; Lessan-Pezeshki M; Nourbala MH; Simforoosh N; Pourfarziani V; Nemati E; Nafar M; Basiri A; Pour-Reza-Gholi F; Firoozan A; Ghadiani MH; Makhdoomi K; Ghafari A; Ahmadpour P; Oliaei F; Ardalan MR; Makhlogh A; Samimagham HR; Azmandian J
Int Urol Nephrol; 2009; 41(3):679-85. PubMed ID: 19009366
[TBL] [Abstract][Full Text] [Related]
31. Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation.
Cherikh WS; Kauffman HM; McBride MA; Maghirang J; Swinnen LJ; Hanto DW
Transplantation; 2003 Nov; 76(9):1289-93. PubMed ID: 14627905
[TBL] [Abstract][Full Text] [Related]
32. De novo tumors after kidney transplantation: the Budapest experience.
Langer RM; Járay J; Tóth A; Hídvégi M; Végsö G; Perner F
Transplant Proc; 2003 Jun; 35(4):1396-8. PubMed ID: 12826170
[TBL] [Abstract][Full Text] [Related]
33. De novo malignances in pediatric organ transplant recipients.
Penn I
Pediatr Transplant; 1998 Feb; 2(1):56-63. PubMed ID: 10084762
[TBL] [Abstract][Full Text] [Related]
34. Posttransplant malignancies in renal transplant recipients: 22-years experience from a single center in Pakistan.
Yunus M; Aziz T; Mubarak M
Asian Pac J Cancer Prev; 2012; 13(2):575-8. PubMed ID: 22524827
[TBL] [Abstract][Full Text] [Related]
35. [Skin cancer in renal transplant recipients].
Mangino M; Schena FP
G Ital Nefrol; 2010; 27 Suppl 50():S75-80. PubMed ID: 20922700
[TBL] [Abstract][Full Text] [Related]
36. Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience.
Ju MK; Joo DJ; Kim SJ; Huh KH; Kim MS; Jeon KO; Kim HJ; Kim SI; Kim YS
Transpl Int; 2009 Jun; 22(6):644-53. PubMed ID: 19220824
[TBL] [Abstract][Full Text] [Related]
37. Abdominal computed tomography findings of malignant tumors in patients with solid organ transplants.
Ulu EM; Tutar NU; Coskun M; Tore HG; Guvenc Z; Haberal M
Transplant Proc; 2007 May; 39(4):1066-70. PubMed ID: 17524893
[TBL] [Abstract][Full Text] [Related]
38. Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients. Groupe Cooperatif de Transplantation d' Ile de France (GCIF).
Farge D; Lebbé C; Marjanovic Z; Tuppin P; Mouquet C; Peraldi MN; Lang P; Hiesse C; Antoine C; Legendre C; Bedrossian J; Gagnadoux MF; Loirat C; Pellet C; Sheldon J; Golmard JL; Agbalika F; Schulz TF
Transplantation; 1999 May; 67(9):1236-42. PubMed ID: 10342315
[TBL] [Abstract][Full Text] [Related]
39. CNI withdrawal for post-transplant lymphoproliferative disorders in kidney transplant is an independent risk factor for graft failure and mortality.
Rabot N; Büchler M; Foucher Y; Moreau A; Debiais C; Machet MC; Kessler M; Morelon E; Thierry A; Legendre C; Rivalan J; Kamar N; Dantal J
Transpl Int; 2014 Sep; 27(9):956-65. PubMed ID: 24964147
[TBL] [Abstract][Full Text] [Related]
40. Comparison of demographic data and immunosupression protocol in patients with and without malignancy after kidney transplantation.
Akbarzadehpasha A; Oliaei F; Asrari MR; Alizadeh-Navaei R
Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1044-7. PubMed ID: 21060171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
